At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LH Labcorp Holdings Inc
Not Yet Opened 10-27 16:00:00 EDT
331.17
+1.27
+0.38%
盘后331.17
+0.000.00%
19:30 EDT
High332.34Low326.32Vol799.60K
Open330.26D1 Closing329.90Amplitude1.82%
Mkt Cap26.79BTradable Cap26.66BTotal Shares80.90M
T/O263.19MT/O Rate0.99%Tradable Shares80.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: Labcorp Holdings Inc Q3 revenue is expected to increase by 5.62%, and institutional views are constructive
Earnings Agent  ·  10-21
Earning Preview: Labcorp Holdings Inc Q3 revenue is expected to increase by 5.62%, and institutional views are constructive
Centene Corp. Stock Underperforms Monday When Compared to Competitors
Dow Jones  ·  10-27 04:56
Centene Corp. Stock Underperforms Monday When Compared to Competitors
Centene Corp. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  10-24
Centene Corp. Stock Underperforms Friday When Compared to Competitors
Waters, Labcorp partner to expand access to cervical cancer screening
TIPRANKS  ·  10-23
Waters, Labcorp partner to expand access to cervical cancer screening
Labcorp Agrees to Acquire Millennium Health
Reuters  ·  10-23
Labcorp Agrees to Acquire Millennium Health
Waters Partners with Labcorp to Expand Access to Cervical Cancer Screening
Reuters  ·  10-23
Waters Partners with Labcorp to Expand Access to Cervical Cancer Screening
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved Hpv Testing Option Beginning in Late 2026
THOMSON REUTERS  ·  10-23
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved Hpv Testing Option Beginning in Late 2026
Waters Corp - Co and Labcorp to Offer Bd Onclarity Hpv Assay by End of 2026
THOMSON REUTERS  ·  10-23
Waters Corp - Co and Labcorp to Offer Bd Onclarity Hpv Assay by End of 2026
Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  10-23
Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day
Centene Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains
Dow Jones  ·  10-23
Centene Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains
Charles River Partners with FDA, Labcorp to Develop Drug Abuse Potential Assessment Tools
Reuters  ·  10-23
Charles River Partners with FDA, Labcorp to Develop Drug Abuse Potential Assessment Tools
Charles River Laboratories International - Agreement Establishes Joint Framework for Standardized Abuse Potential Metrics in Preclinical Models
THOMSON REUTERS  ·  10-23
Charles River Laboratories International - Agreement Establishes Joint Framework for Standardized Abuse Potential Metrics in Preclinical Models
Labcorp Holdings Announces Dividend of R$ 0.61222973 Per Unit
Reuters  ·  10-23
Labcorp Holdings Announces Dividend of R$ 0.61222973 Per Unit
Labcorp Maintains Quarterly Dividend at $0.72 a Share, Payable on Dec. 11 to Shareholders of Record on Nov. 24
MT Newswires Live  ·  10-21
Labcorp Maintains Quarterly Dividend at $0.72 a Share, Payable on Dec. 11 to Shareholders of Record on Nov. 24
Press Release: Labcorp Declares Quarterly Dividend
Dow Jones  ·  10-21
Press Release: Labcorp Declares Quarterly Dividend
Myriad Genetics Shares Rise 19% Premarket After Co Agrees to Sell Prenatal Health Testing Business to Labcorp
THOMSON REUTERS  ·  10-20
Myriad Genetics Shares Rise 19% Premarket After Co Agrees to Sell Prenatal Health Testing Business to Labcorp
Myriad Genetics - Labcorp Expects $160 Mln Revenue Addition and Slightly Accretive to Adj Earnings in Year One from Deal
THOMSON REUTERS  ·  10-20
Myriad Genetics - Labcorp Expects $160 Mln Revenue Addition and Slightly Accretive to Adj Earnings in Year One from Deal
Myriad Genetics - Deal Expected to Close by Early 2027 Pending Regulatory Clearance
THOMSON REUTERS  ·  10-20
Myriad Genetics - Deal Expected to Close by Early 2027 Pending Regulatory Clearance
Myriad Genetics - to Sell Prenatal Health Testing Business to Labcorp for $210 Mln Cash Plus Inventory
THOMSON REUTERS  ·  10-20
Myriad Genetics - to Sell Prenatal Health Testing Business to Labcorp for $210 Mln Cash Plus Inventory
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
GlobeNewswire  ·  10-20
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp

Introduction

Company Name.
Labcorp Holdings Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Labcorp Holdings Inc. is a Delaware corporation founded in 1971 and a leading global life sciences company deeply integrated into patient care guidance. The company provides comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. Positioned at the convergence of research and care delivery, LabCorp combines world-class diagnostics and drug development capabilities to enable more precise and personalized healthcare.
Issue price:
--